Dissertation > Excellent graduate degree dissertation topics show

The Prevention Effect of Hydration Therapy on Contrast-induced Nephropathy of Diabetic Nephropathy Patients

Author: TanMingHong
Tutor: ChenBing
School: Third Military Medical University
Course: Endocrine and metabolic diseases
Keywords: diabetic nephropathy contrast-induced nephropathy non-ionic iso-osmolar contrast medium Saline hydration therapy
CLC: R692.9
Type: Master's thesis
Year: 2011
Downloads: 49
Quote: 0
Read: Download Dissertation

Abstract


Background and ObjectiveDiabetic nephropathy is a major complication of diabetes, which occurs in 47.66% of the patients. Patients with diabetic nephropathy in clinical often due to be multi-detector row spiral ranks computed tomography examination, which need to use iodine contrast media inevitablly. The current global use of iodine contrast media has reached hundreds of millions of people-time each year. The expansion in the use of iodinated contrast media means that the incidence of CIN, which not only does negatively impact clinical outcomes, but it is also associated with increased healthcare costs, is likely to grow rapidly. So it is necessary to study how to reduce the diabetic patients in contrast-induced nephropathy occurred in check.Contrast-induced nephropathy (CIN) is defined as either a greater than 25% increase of serum creatinine or an absolute increase in serum creatinine of 0.5 mg/dL after a radiographic examination using a contrast agent. CIN is the third most common cause of hospital-acquired renal failure and is a substantial cause of morbidity and mortality. The rate of CIN for non-selected population can vary from 1% to 6% and this will be up to 50% for high-risk group. CIN typically results in acute renal dysfunction with the increase in creatinine level occurring within 24-48 hours that often peaks at 3-5 days. However, there is currenttly no efficient and cost-effective treatment measures, mainly focusing on prevention, and the prevention effect of hydration therapy has become widely recognized as a regular means of prevention of CIN. This paper studies the prevention effect of hydration therapy on contrast-induced nephropathy (CIN) of diabetic nephropathy patients using non-ionic iso-osmolar contrast medium.Methods1. Clinical data A total of 80 diabetic nephropathy patients who were admitted to endocrinology department of southwest hospital from January 2007 to December 2010 were involved in this study. The age, sex, height, weight, body mass index, heart rate, blood pressure, glycated hemoglobin, urinary albumin, serum creatinine, blood urea nitrogen, cystatin C, calculated glomerular filtration rate, total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol, triglycerides and fasting blood glucose were recorded.2. Inclusion criteria(1) Subject is a male or female and before the study SCr≥1.7mg/dL(150umol/L) for male and SCr≥1.5mg/dL(150umol/L) for female,or eGFR≤50mL/min/1.73m2 and eGFR≥30mL/min/1.73m2 by MDRD formula.(2) Diabetes (typeⅠor TypeⅡ), more than lyear with subcutaneous insulin and oral hypoglycemic agents.(3) 18+years of age(4) Subject agrees not to participate in a conception process and to use of contraception as specified in the protocol.3. Exclusion criteria(1) Subject with serious disease, acute renal failure, kidney transplant, end stage renal disease dialysis line, severe hepatic insufficiency, and congestive heart failure symptoms(2) Pregnancy and breast feeding(3) Subject had used use of metformin the day before 3 days to 7 days of the study and other exclusion exceptions.4. Grouping and methodsThey were randomly divided into two groups:①saline hydration group (n=39), which received intravenous 0.9% NaCl solution at a rate of 1 ml/kg/h for 12 hours before and after contrast media administration for multidetector-row helical computerized tomography(MDCT). The quantity of fluid was adjusted according to body weight and cardiac function. At least two liters the urine volume of 24h were required for sufficient hydration,①conventional therapy group, which received no additional water and fluid therapy.5. Outcome measuresAll patients received non-ionic iso-osmolar contrast medium(iodixanol 320 mg /ml)and their serum creatinine (SCr) just before and after 48 hours,72 hours,168 hours of administration were recorded and analyzed.6. Serious adverse eventsUremia or death due to rapid deterioration of kidney function7. Statistical analysisData are presented as mean x±s. Characteristics of patients between groups were compared using single analysis of variance. For all analyses an alpha of 0.05 was used to define statistical significance.Results1. Serum creatinine levelsThe baseline of SCr in saline hydration group was 160.9±62.7umol/L. After 48 hours,72 h and 168 hours of non-ionic iso-osmolar contrast medium administration, the SCr was 145.8±78.7umol/L、143.1±47.6umol/L、153.8±59.8umol/L, respectively.There was no difference among them(P>0.05). The baseline of SCr in conventional therapy group was 180.3±91.4umol/L. After 48 hours,72 h and 168 hours of non-ionic iso-osmolar contrast medium administration, the SCr was 145.8±78.7umol/L、143.1±47.6umol/L、153.8±59.8umol/L, respectively. The SCr shows no difference before and after administration in the conventional therapy group, either (P>0.05).2. Incidence of CINThe incidence of CIN was lower in hydration group than that in conventional therapy group(OV17.9%,P<0.05)3. Serious adverse eventsThere was no one case of uremia or death.Conclusion1. The incidence of CIN is lowered when saline hydration is used.2. The incidence of contrast-induced nephropathy for high-risk patients can be reduced through the selection of contrast agent formulation and the adjustment dose of contrast medium.

Related Dissertations

  1. Based on the tutor clinical experience in medical treatment of chronic kidney disease proteinuria,R277.5
  2. C-reactive protein,homocysteine ??levels in type 2 diabetic peripheral neuropathy of TCM,R259
  3. The Effects of Atorvastatin on Expression of Osteopontin in Kidney of the Diabetic Rats Its Molecular Mechanism,R587.2
  4. DPP-IV inhibitors of the synthesis and activity of,R914
  5. Low Dose of Spironolactone Reduces Oxidative Stress and Prevents the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus,R587.2
  6. Study on Therapy and Mechanisms of the Role of Tang Kang in Diabetic Rat and Endothelial Cells,R285.5
  7. Effects of Stress High Glucose on Prognosis Non-diabetes Patients with Myocardial Infraction,R542.22
  8. Effect of Swimming in Cold Water on Function and Structure of Peripheral Nerve in Diabetic Rats,R587.1
  9. Intravitreal Injection of Bevacizumab Combined Triamcinolone Acetonide for Diabetic Macular Edema,R774.5
  10. Adiponectin , leptin and type 2 diabetic retinopathy correlation of,R774.1
  11. Human adipose -derived mesenchymal stem cells to treat diabetic nephropathy rat studies,R692
  12. Diabetic retinopathy OK vitrectomy surgery intraocular lens implantation in different periods of clinical observation,R779.66
  13. The Changes of T Lymphocyte Subsets and Costimulatory Molecules Before and After Shuxuetong Treatment in Type 2 Diabetes Subjects with Diabetic Kidney Disease,R692
  14. The Expression of Neuroglobin in Retina of Diabetic Rats,R774.1
  15. The Study of Klotho Gene Expression Level in Debetics Nephometic Patients in Vivo,R692.9
  16. Correlation of type 2 diabetes serum TGF-β1 and PDGF-BB levels and urinary albumin excretion rate in patients with kidney disease,R587.2
  17. The Influence of Tripeterygium Wilfordii on Urine Podocyte Injury in Diabetic Kidney Disease Patients,R587.2
  18. Relation of Serum Vaspin Level to Type 2 Diabetes and Microangiopathy of Diabetes,R587.1
  19. Wheat starch, dietary intervention on early diabetic kidney damage reversal effect of,R692.9
  20. Modified Zhulingtang treatment of diabetic nephropathy Ⅳ stage clinical study,R692.9
  21. Study on the Mechanism of Metabolic Mem Ory of Hyperglycemia on Injury of Endothe Lial Cells,R587.1

CLC: > Medicine, health > Surgery > Urology ( urinary and reproductive system diseases) > Kidney disease > Other diseases
© 2012 www.DissertationTopic.Net  Mobile